Trade Mark Journal No.2025/038 19 September 2025
WO0000001874167 (5,44)
Office of origin: Japan
Date of International Registration:10 July 2025
Date of designation in the UK:
10 July 2025

- Class 5
- Pharmaceutical preparations; pharmaceutical preparations for treatment of erythropoietic protoporphyria and X-linked protoporphyria.
- Class 44
- Providing medical information of erythropoietic protoporphyria and X-linked protoporphyria; providing medical information, consultancy and advisory services.
Mitsubishi Tanabe Pharma Corporation
Representative: YAMAO Norihito, AOYAMA & PARTNERS,, Osaka Umeda Twin Towers North,, 8-1, Kakuda-cho,, Kita-ku, Osaka-shi, Osaka 530-0017, JAPAN